Stryker Corp
NYSE:SYK

Watchlist Manager
Stryker Corp Logo
Stryker Corp
NYSE:SYK
Watchlist
Price: 384.85 USD -1.36% Market Closed
Market Cap: 146.7B USD
Have any thoughts about
Stryker Corp?
Write Note

Intrinsic Value

The intrinsic value of one SYK stock under the Base Case scenario is 287.61 USD. Compared to the current market price of 384.85 USD, Stryker Corp is Overvalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SYK Intrinsic Value
287.61 USD
Overvaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Stryker Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SYK cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SYK?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Stryker Corp

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Stryker Corp

Provide an overview of the primary business activities
of Stryker Corp.

What unique competitive advantages
does Stryker Corp hold over its rivals?

What risks and challenges
does Stryker Corp face in the near future?

Has there been any significant insider trading activity
in Stryker Corp recently?

Summarize the latest earnings call
of Stryker Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Stryker Corp.

Provide P/S
for Stryker Corp.

Provide P/E
for Stryker Corp.

Provide P/OCF
for Stryker Corp.

Provide P/FCFE
for Stryker Corp.

Provide P/B
for Stryker Corp.

Provide EV/S
for Stryker Corp.

Provide EV/GP
for Stryker Corp.

Provide EV/EBITDA
for Stryker Corp.

Provide EV/EBIT
for Stryker Corp.

Provide EV/OCF
for Stryker Corp.

Provide EV/FCFF
for Stryker Corp.

Provide EV/IC
for Stryker Corp.

Show me price targets
for Stryker Corp made by professional analysts.

What are the Revenue projections
for Stryker Corp?

How accurate were the past Revenue estimates
for Stryker Corp?

What are the Net Income projections
for Stryker Corp?

How accurate were the past Net Income estimates
for Stryker Corp?

What are the EPS projections
for Stryker Corp?

How accurate were the past EPS estimates
for Stryker Corp?

What are the EBIT projections
for Stryker Corp?

How accurate were the past EBIT estimates
for Stryker Corp?

Compare the revenue forecasts
for Stryker Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Stryker Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Stryker Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Stryker Corp compared to its peers.

Compare the P/E ratios
of Stryker Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Stryker Corp with its peers.

Analyze the financial leverage
of Stryker Corp compared to its main competitors.

Show all profitability ratios
for Stryker Corp.

Provide ROE
for Stryker Corp.

Provide ROA
for Stryker Corp.

Provide ROIC
for Stryker Corp.

Provide ROCE
for Stryker Corp.

Provide Gross Margin
for Stryker Corp.

Provide Operating Margin
for Stryker Corp.

Provide Net Margin
for Stryker Corp.

Provide FCF Margin
for Stryker Corp.

Show all solvency ratios
for Stryker Corp.

Provide D/E Ratio
for Stryker Corp.

Provide D/A Ratio
for Stryker Corp.

Provide Interest Coverage Ratio
for Stryker Corp.

Provide Altman Z-Score Ratio
for Stryker Corp.

Provide Quick Ratio
for Stryker Corp.

Provide Current Ratio
for Stryker Corp.

Provide Cash Ratio
for Stryker Corp.

What is the historical Revenue growth
over the last 5 years for Stryker Corp?

What is the historical Net Income growth
over the last 5 years for Stryker Corp?

What is the current Free Cash Flow
of Stryker Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Stryker Corp.

Business Breakdown

Stryker Corporation, a prominent player in the global medical technology landscape, has carved out a reputation for innovation and reliability since its founding in 1941. Specializing in developing and manufacturing a diverse range of products, Stryker's offerings span surgical equipment, implantable devices, and medical instruments, all designed to enhance patient care and improve clinical outcomes. Fueled by a commitment to quality and continuous improvement, the company invests heavily in research and development, leading the way with cutting-edge technologies like robotic surgical systems and advanced orthopedic solutions. The company’s strong market position is bolstered by its strategi...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Stryker Corp

Current Assets 14.7B
Cash & Short-Term Investments 4.7B
Receivables 3.7B
Other Current Assets 6.3B
Non-Current Assets 29.2B
PP&E 3.9B
Intangibles 21.3B
Other Non-Current Assets 3.9B
Current Liabilities 7.7B
Accounts Payable 1.3B
Accrued Liabilities 3.5B
Other Current Liabilities 2.9B
Non-Current Liabilities 16B
Long-Term Debt 13.3B
Other Non-Current Liabilities 2.7B
Efficiency

Earnings Waterfall
Stryker Corp

Revenue
22B USD
Cost of Revenue
-7.9B USD
Gross Profit
14B USD
Operating Expenses
-9.2B USD
Operating Income
4.8B USD
Other Expenses
-1.2B USD
Net Income
3.6B USD

Free Cash Flow Analysis
Stryker Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Stryker reported robust organic sales growth of 11.5% in Q3 2024, driven by strong performances in MedSurg, Neurotechnology, and Orthopaedics. Adjusted EPS reached $2.87, up 16.7% year-over-year. Management now anticipates full-year organic sales growth of 9.5% to 10%, alongside adjusted EPS guidance of $12 to $12.10. The company highlighted successful M&A activities, strengthening its portfolio and addressing emerging healthcare needs. Stryker also targets 200 basis points of margin expansion by 2025, focusing on operational efficiencies amid steady demand for robotic-assisted procedures and ongoing product innovations.

What is Earnings Call?
Fundamental Scores

SYK Profitability Score
Profitability Due Diligence

Stryker Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Year Average ROE
62/100
Profitability
Score

Stryker Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

SYK Solvency Score
Solvency Due Diligence

Stryker Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
64/100
Solvency
Score

Stryker Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SYK Price Targets Summary
Stryker Corp

Wall Street analysts forecast SYK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SYK is 409.65 USD with a low forecast of 373.7 USD and a high forecast of 472.5 USD.

Lowest
Price Target
373.7 USD
3% Downside
Average
Price Target
409.65 USD
6% Upside
Highest
Price Target
472.5 USD
23% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SYK?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SYK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SYK Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

SYK News

Other Videos

Profile

Stryker Corp Logo
Stryker Corp

Country

United States of America

Industry

Health Care

Market Cap

146.7B USD

Dividend Yield

0.83%

Description

Stryker Corp. engages in the provision of medical technology products and services. The company is headquartered in Portage, Michigan and currently employs 46,000 full-time employees. The firm offers products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine that help improve patient and hospital outcomes. Its products are sold in approximately 75 countries through Company-owned subsidiaries and branches, as well as, third-party dealers and distributors. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a range of medical specialties. Its business segments include MedSurg and Neurotechnology and Orthopaedics and Spine. Its subsidiaries include Alcott Indemnity Company, Arrinex, Inc., Berchtold Corporation, and BioMimetic Therapeutics, LLC.

Contact

MICHIGAN
Portage
2825 Airview Blvd
+12693892600.0
www.stryker.com

IPO

1980-03-17

Employees

46 000

Officers

Chairman, CEO & President
Mr. Kevin A. Lobo
VP & CFO
Mr. Glenn S. Boehnlein
Group President of Global Quality & Operations
Mr. Viju S. Menon
Group President of MedSurg & Neurotechnology
Mr. J. Andrew Pierce
Group President of Orthopaedics & Spine
Mr. Spencer S. Stiles
VP & Chief Accounting Officer
Mr. William E. Berry Jr.
Show More
CTO and VP of Global R&D - Joint Replacement
Mr. Robert C. Cohen
VP, Chief Information Officer & Chief Information Security Officer
Mr. Alan Douville
Vice President of Finance & Investor Relations
Mr. Jason Beach
VP & Chief Legal Officer
Mr. Robert S. Fletcher
Show Less

See Also

Discover More
What is the Intrinsic Value of one SYK stock?

The intrinsic value of one SYK stock under the Base Case scenario is 287.61 USD.

Is SYK stock undervalued or overvalued?

Compared to the current market price of 384.85 USD, Stryker Corp is Overvalued by 25%.

Back to Top